Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
HOCH Abgang Schlüsselpersonen (17.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 17.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | on June 12, 2025, including under the heading “Item 5.02. Departure of Directors or Certain Officers; Election of Direct |
| 20.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | eto, which is incorporated by reference into this Item 5.02. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits: E |
Stammdaten
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Unternehmen & Branche
| Name | DANAHER CORP /DE/ |
|---|---|
| Ticker | DHR |
| CIK | 0000313616 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 3823 · Industrial Instruments For Measurement, Display, and Control |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 126,68 Mrd. USD |
| Beta | 0,99 |
| Dividendenrendite | 1,36 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-27 | 10-Q | 5,951,000,000 | 1,029,000,000 | 1.45 | 83,544,000,000 | 52,949,000,000 |
| 2025-12-31 | 10-K | 24,568,000,000 | 3,614,000,000 | 5.05 | 83,464,000,000 | 52,534,000,000 |
| 2025-09-26 | 10-Q | 6,053,000,000 | 908,000,000 | 1.27 | 79,897,000,000 | 51,071,000,000 |
| 2025-06-27 | 10-Q | 5,936,000,000 | 555,000,000 | 0.77 | 81,620,000,000 | 52,334,000,000 |
| 2025-03-28 | 10-Q | 5,741,000,000 | 954,000,000 | 1.32 | 79,116,000,000 | 50,849,000,000 |
| 2024-12-31 | 10-K | 23,875,000,000 | 3,899,000,000 | 5.29 | 77,542,000,000 | 49,543,000,000 |
| 2024-09-27 | 10-Q | 5,798,000,000 | 818,000,000 | 1.12 | 80,615,000,000 | 51,299,000,000 |
| 2024-06-28 | 10-Q | 5,743,000,000 | 907,000,000 | 1.22 | 78,555,000,000 | 49,897,000,000 |
| 2024-03-29 | 10-Q | 5,796,000,000 | 1,088,000,000 | 1.45 | 83,402,000,000 | 53,442,000,000 |
| 2023-12-31 | 10-K | 6,405,000,000 | 4,764,000,000 | 1.45 | 84,488,000,000 | 53,486,000,000 |
| 2023-09-29 | 10-K | 5,624,000,000 | 1.51 | |||
| 2023-09-29 | 10-Q | 5,624,000,000 | 1,129,000,000 | 1.51 | 87,734,000,000 | 52,407,000,000 |
| 2023-06-30 | 10-Q | 5,912,000,000 | 1,106,000,000 | 1.49 | 84,902,000,000 | 51,716,000,000 |
| 2023-06-30 | 10-K | 5,912,000,000 | 1.49 | |||
| 2023-03-31 | 10-Q | 5,949,000,000 | 1,450,000,000 | 1.94 | 85,040,000,000 | 51,478,000,000 |
| 2023-03-31 | 10-K | 5,949,000,000 | 1.94 | |||
| 2022-12-31 | 10-K | 7,134,000,000 | 7,209,000,000 | 2.99 | 84,350,000,000 | 50,082,000,000 |
| 2022-09-30 | 10-Q | 7,663,000,000 | 1,572,000,000 | 2.10 | 81,030,000,000 | 46,985,000,000 |
| 2022-09-30 | 10-K | 6,455,000,000 | 2.10 | |||
| 2022-07-01 | 10-Q | 7,751,000,000 | 1,680,000,000 | 2.25 | 81,806,000,000 | 46,594,000,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | Milosevich Gregory M | Officer, Executive Vice President | Open Market Sale | -1,320 | 208.01 | -274,574.52 | -1,5% | |
| 2025-11-25 | RALES MITCHELL P | Director, Officer, Chairman of Exec. Committee | Open Market Sale | -35,899 | 230.27 | -8,266,462.73 | -45,1% | |
| 2025-11-25 | RALES MITCHELL P | Director, Officer, Chairman of Exec. Committee | Open Market Sale | -4,726 | 231.19 | -1,092,603.94 | -6,0% | |
| 2025-11-18 | List Teri | Director | Open Market Sale | -3,298 | 226.50 | -746,997.00 | -4,1% | |
| 2025-11-12 | RALES MITCHELL P | Director, Officer, Chairman of Exec. Committee | Open Market Sale | -133,233 | 219.43 | -29,235,317.19 | -159,6% | |
| 2025-11-12 | RALES MITCHELL P | Director, Officer, Chairman of Exec. Committee | Open Market Sale | -254,553 | 218.27 | -55,561,283.31 | -303,3% | |
| 2025-11-12 | RALES MITCHELL P | Director, Officer, Chairman of Exec. Committee | Open Market Sale | -23,359 | 220.15 | -5,142,483.85 | -28,1% | |
| 2025-11-12 | Ellis Brian W | Officer, Senior Vice President - GC | Open Market Sale | -14,667 | 219.23 | -3,215,477.21 | -17,6% | |
| 2025-11-12 | Ellis Brian W | Officer, Senior Vice President - GC | Open Market Sale | -7,109 | 219.21 | -1,558,385.93 | -8,5% | |
| 2025-11-12 | RALES MITCHELL P | Director, Officer, Chairman of Exec. Committee | Open Market Sale | -25,855 | 217.64 | -5,627,082.20 | -30,7% | |
| 2025-11-11 | McGrew Matthew | Officer, EVP & Chief Financial Officer | Open Market Sale | -16,172 | 214.62 | -3,470,831.41 | -18,9% | |
| 2025-11-10 | Couchara Georgeann | Officer, SVP, Human Resources | Open Market Sale | -4,176 | 210.44 | -878,812.47 | -4,8% | |
| 2025-11-10 | Couchara Georgeann | Officer, SVP, Human Resources | Open Market Sale | -998 | 210.31 | -209,891.18 | -1,1% | |
| 2025-10-31 | RALES MITCHELL P | Director, Officer, Chairman of Exec. Committee | Open Market Sale | -308,423 | 215.67 | -66,517,588.41 | -363,2% | |
| 2025-10-31 | RALES MITCHELL P | Director, Officer, Chairman of Exec. Committee | Open Market Sale | -68,128 | 217.17 | -14,795,357.76 | -80,8% | |
| 2025-10-31 | RALES MITCHELL P | Director, Officer, Chairman of Exec. Committee | Open Market Sale | -223,449 | 216.26 | -48,323,080.74 | -263,8% | |
| 2025-08-22 | List Teri | Director | Open Market Sale | -2,778 | 211.06 | -586,319.12 | -3,2% | |
| 2025-05-12 | RALES STEVEN M | Director, Officer, Chairman | Open Market Sale | -355,668 | 194.97 | -69,344,589.96 | -378,6% | |
| 2025-05-12 | RALES STEVEN M | Director, Officer, Chairman | Open Market Sale | -189,314 | 197.06 | -37,306,216.84 | -203,7% | |
| 2025-05-12 | RALES STEVEN M | Director, Officer, Chairman | Open Market Sale | -166,225 | 194.08 | -32,260,948.00 | -176,1% | |
| 2025-05-12 | RALES STEVEN M | Director, Officer, Chairman | Open Market Sale | -164,412 | 199.15 | -32,742,649.80 | -178,8% | |
| 2025-05-12 | RALES STEVEN M | Director, Officer, Chairman | Open Market Sale | -158,951 | 199.67 | -31,737,746.17 | -173,3% | |
| 2025-05-12 | RALES STEVEN M | Director, Officer, Chairman | Open Market Sale | -109,801 | 195.69 | -21,486,957.69 | -117,3% | |
| 2025-05-12 | RALES STEVEN M | Director, Officer, Chairman | Open Market Sale | -47,316 | 200.83 | -9,502,472.28 | -51,9% | |
| 2025-05-12 | RALES STEVEN M | Director, Officer, Chairman | Open Market Sale | -58,313 | 197.86 | -11,537,810.18 | -63,0% | |
| 2025-04-30 | Riley Christopher Paul | Officer, Executive Vice President | Open Market Sale | -8,004 | 198.05 | -1,585,216.21 | -8,7% | |
| 2025-04-30 | Riley Christopher Paul | Officer, Executive Vice President | Open Market Sale | -7,801 | 197.95 | -1,544,207.95 | -8,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.